News Hunan Jingfeng Pharmaceutical Co.,Ltd.

Equities

000908

CNE000000Y11

End-of-day quote Shenzhen S.E. Other stock markets 23:00:00 30/05/2024 BST			5-day change	1st Jan Change
1.8 ^CNY	-4.76%		-8.16%	-44.44%

04-29	Hunan Jingfeng Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
04-29	Hunan Jingfeng Pharmaceutical Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Summary

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Hunan Jingfeng Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	04-29	CI
Hunan Jingfeng Pharmaceutical Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	04-29	CI
Hunan Jingfeng Pharmaceutical Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	30/10/23	CI
Hunan Jingfeng Pharmaceutical Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	27/08/23	CI
Hunan Jingfeng Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	28/04/23	CI
Jingfeng Pharmaceutical Unit Sells Property for $16.8 Million	18/11/22	MT
Hunan Jingfeng Pharmaceutical Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	30/10/22	CI
Hunan Jingfeng Pharmaceutical Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	29/08/22	CI
Hunan Jingfeng Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	29/04/22	CI
Beijing Zhouyu Energy Technology Co., Ltd. completed the acquisition of a 5% stake in Hunan Jingfeng Pharmaceutical Co.,Ltd. from Ye Xiangwu, Ye Gaojing, and Ye Xianglun.	02/03/22	CI
Hunan Jingfeng Pharmaceutical Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021	27/10/21	CI
Beijing Zhouyu Energy Technology Co., Ltd. signed the share transfer agreement to acquire a 5% stake in Hunan Jingfeng Pharmaceutical Co.,Ltd. from Ye Xiangwu, Ye Gaojing, and Ye Xianglun for approximately CNY 220 million.	11/10/21	CI
Hunan Jingfeng Pharmaceutical Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021	29/08/21	CI
Hunan Jingfeng Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2021	29/04/21	CI
Hunan Jingfeng Pharmaceutical Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2020	29/04/21	CI
Hunan Jingfeng Pharmaceutical Co.,Ltd. Announces Management Changes	27/01/21	CI
Hunan Jingfeng Pharmaceutical Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2020	29/10/20	CI
Hangzhou Fuyue Yize Equity Investment Partnership Enterprise (Limited Partnership) completed the acquisition of a 20% stake in Wisdom Pharmaceutical Co., Ltd. from Hunan Jingfeng Pharmaceutical Co.,Ltd..	15/10/20	CI
Hangzhou Fuyue Yize Equity Investment Partnership Enterprise (Limited Partnership) signed a share transfer agreement to acquire a 20% stake in Wisdom Pharmaceutical Co., Ltd. from Hunan Jingfeng Pharmaceutical Co.,Ltd. for approximately CNY 160 million.	11/09/20	CI
Hunan Jingfeng Pharmaceutical Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2020	27/08/20	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Hunan Jingfeng Pharmaceutical Co.,Ltd.

Equities

000908

CNE000000Y11

Summary

Filters